The current institutional shareholding score of Mereo BioPharma Group PLC is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 43.84%, representing a quarter-over-quarter decrease of 38.82%. The largest institutional shareholder is James Simons, holding a total of 48.59K shares, representing 0.03% of shares outstanding, with 0.99% decrease in holdings.